To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Amendment to Purchase Order with Sanofi Pasteur Inc.
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, an amendment to purchase order #31625 with Sanofi Pasteur Inc., to increase the payment limit by $150,000 to a new amount not to exceed $725,000 for the purchase of vaccines and injectable medications at Contra Costa Medical Center (CCRMC) and Contra Costa Health Centers, with no change in the term ending December 31, 2025.
FISCAL IMPACT:
Approval of this action will result in additional expenditures of up to $150,000 and will be funded by Hospital Enterprise Fund I revenues.
BACKGROUND:
Sanofi Pasteur Inc. furnishes pharmaceuticals for patient care provided in the hospital and clinics. These vaccines and other injectable medications are essential for patient care. Sanofi is the maker of critical injectables for the hospital including Insulin for Type I and Type II diabetic patients, vaccines, and different immune globulin formulations including Intravenous Immune Globulin (IVIG), a life-saving medication used to treat primary immunodeficiency to reduce the risk of infection in individuals with poorly functioning immune systems. IVIG is also used to increase platelets (blood clotting cells) in people with idiopathic thrombocytopenic purpura (ITP) and to prevent aneurysms caused by a weakening of the main artery in the heart associated with Kawasaki syndrome.
The CCRMC Pharmacy purchased more flu vaccines for all Contra Costa Health Centers and hospital for the 2025-2026 flu season due to the fact that the State provided fewer State General Fund (SGF) flu vaccines compared to the previous year. Additionally a new vaccine, Beyfortus, was purchased starting 2024 for prevention of respiratory syncytial virus (RSV) infection in newborn babies. This vaccine was approved in 2024, and it was a new addition to Sanofi’s list of available vaccines and only available through the manufacturer, Sanofi.
On December 17, 2024 the Board of Supervisors approved agenda item C.142 to execute a purchase order (#31625) with Sanofi Pasteur in an amount of $575,000.00 for vaccines and injectable medications for the period of January 1, 2025, through December 31, 2025.
On October 1, 2025 the Purchasing Agent approved the continued use of Sanofi Pasteur Inc.
Approval of this action will increase the payment limit on an existing purchase order and allow this vendor to continue providing vaccines and injectable medications to CCRMC and Health Centers through December 31, 2025.
CONSEQUENCE OF NEGATIVE ACTION:
If this action is not approved, CCRMC will not be able to provide needed vaccines and other pharmaceutical products to our patient population. As part of our responsibility as a health care organization, we must provide needed vaccinations to our patient population in order to prevent disease, as well as prevent the spread of disease.